Additionally, we demonstrated RSK-dependent phosphorylation of LARG at S1288 in a PDX cell line as well as a positive correlation between pLARG S1288 and activated RhoA-GTP expression in primary tumor samples, indicating that this pathway is conserved in patient GBM tissue as well as in established cell lines. The gene discussed is RPS6KA3; the disease is glioblastoma.